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Abstract
A well-documented challenge in moving public health research into practice is the extended time 
it takes to implement findings in clinical practice and communities. The Evidence Academy model 
(Rohweder et al., 2016), developed and first used in North Carolina, is a pragmatic, action-
oriented model that aims to shorten this timeline by communicating cutting-edge findings directly 
to those who can use them and convening individuals working in a single topic area to network 
and plan activities for the future. The University of Pennsylvania Collaborating Center of the 
Cancer Prevention and Control Research Network (CPCRN) held three conferences based on the 
Evidence Academy model: one about prostate cancer in 2015, a second on food access and obesity 
prevention in 2017, and a third about tobacco control science in 2018. A diverse planning 
committee of stakeholders helped shape the content, focus,and format of each conference. Local 
and national experts presented findings to regional audiences of researchers, practitioners, 
government leaders, and community members. Each Evidence Academy included collaborators 
and speakers from other Prevention Research Centers (PRCs) and CPCRN network sites. 
Evaluations and outcomes indicated that the events were successful in achieving their goals and 
fostered ongoing relationships among attendees. This paper illustrates how the Evidence Academy 
model was used in a different region and describes lessons learned and follow-up activities that 
were initiated via the Evidence Academy and with input from participants. Lessons learned may 
be helpful in developing and evaluating future adaptations of the Evidence Academy model and/or 
the effectiveness of its components.
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1. Introduction
Robust, adaptable models for engaging researchers, clinicians, advocates, and policymakers 
in joint efforts to address important community health priorities using available evidence are 
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needed (Rohweder et al., 2016). Community-engaged initiatives, like the Cancer Prevention 
and Control Research Network (CPCRN), are well-positioned to facilitate the advancement 
of knowledge and application of cutting-edge science, thus accelerating knowledge 
translation, action, and partnerships.
One of the aims of the University of Pennsylvania Prevention Research Center's (UPenn 
PRC) CPCRN Collaborating Center is to expand community-based dissemination and 
implementation research on cancer prevention and control in Southeastern Pennsylvania and 
the surrounding region using Evidence Academies. Evidence Academies are designed to 
bring together researchers, health professionals, advocates, and policy makers to accelerate 
the process of integrating research findings into practice (Rohweder et al., 2016).
This paper illustrates how the Evidence Academy model was used in a different region and 
describes lessons learned and follow-up activities initiated via the Evidence Academies and 
with input from participants.
2. The Evidence Academy model
The “Evidence Academy” education model, developed in North Carolina, is a one-day, 
single-theme meeting focused on an important community health priority. The Evidence 
Academy (EA) model (Rohweder et al., 2016) was used as a guide to plan the UPenn PRC 
events; see Fig. 1 for an example of how the original EA process model was applied for the 
Prostate Cancer Evidence Academy and details about the unique features of EAs.
This model differs from a conventional conference model by creating co-learning 
experiences for a relatively small, well-defined, local or regional network of individuals who 
represent different sectors but share a collective interest in a specific health priority. The 
focus of presentations is cutting-edge research. EAs offer community, clinical, and policy 
tracks during the event; and focus on both short term outcomes such as knowledge transfer, 
awareness, and partnerships, and long term outcomes related to evidence adoption and 
implementation (Rohweder et al., 2016). Events are planned and held locally with the 
guidance of a planning committee. Planning committees should be multidisciplinary, 
representative of affected stakeholders at all relevant levels, and knowledgeable about the 
evidence for the EA topic. For the EA model to be adopted widely or individualized for 
specific user needs, it is important to share examples of how the model has been 
implemented outside where it was first pioneered (Rohweder et al., 2016).
3. Planning the UPenn PRC Evidence Academies
UPenn researchers used the EA model because it provided a template for engaging 
community and other partners in developing EA themes; sharing cutting edge study results 
on issues of importance to community partners; informing local experts and community 
partners of appropriate dissemination and implementation strategies; and framing 
discussions with participants at different community and health systems levels about ways to 
overcome challenges to high quality, consistent implementation of evidence. Specific 
examples of adaptations made to the model for these events include having a more narrow 
geographic focus (i.e., city/regional as compared to state) and creating tracks to reflect the 
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target participants and speaker expertise. Through these EAs, the UPenn PRC aimed to make 
successful community engagement the rule, rather than the exception, in implementing 
evidence-based cancer prevention and control in the communities surrounding UPenn 
(Michener et al., 2012).
Each EA began with the UPenn CPCRN team and community partners identifying the broad 
issue that would be the overarching topic. Issue selection was based on local epidemiologic 
assessments of cancer incidence and mortality, risk factors, and health disparities. The team 
then identified and convened a Planning Committee for each EA. Committee members were 
chosen based on their expertise in the content area and to ensure different groups' interests 
were voiced during the planning process. Membership included clinicians, researchers, 
advocates, and policy makers from local universities and health systems, the State 
Department of Health, and community health organizations. For the Food Access, Diet, and 
Obesity Evidence Academy, faculty and staff from across the Prevention Research Centers 
(PRC) network participated, including individuals from Tulane University, the University of 
Illinois at Chicago, University of Massachusetts Medical School, the CPCRN Coordinating 
Center, and the Nutrition and Obesity Policy, Research, and Evaluation Network 
(NOPREN). The Planning Committee provided recommendations and input for each 
Academy, including refining conference themes, proposing topics, nominating keynote 
speakers, identifying potential event venues, publicizing the event, and serving as session 
moderators.
With support from CPCRN staff, Planning Committee members fine-tuned plans for each 
EA and helped craft agendas and meeting formats, which were planned to maximize 
interaction among attendees. Transmission of new information, by using a combination of 
lectures by experts and small group discussions, was also an important goal. Separate 
“tracks” within each EA were intended to focus on community action, clinical practice, and 
policy as per the original EA model (Rohweder et al., 2016). Evaluation forms were used to 
collect immediate post-EA feedback.
EA registration fees were kept low to engage a diverse audience. Registration included 
breakfast, lunch, refreshments during breaks, and the course syllabus, but did not cover the 
full direct costs of the event (Table 1). Scholarships were offered to increase attendee access, 
especially among community partners and students.
Each event was held from 9:00 am to 4:30 pm on a Friday at a hotel event/meeting space 
near the University of Pennsylvania and convenient to public transportation. EA attendance 
targets were 50 to 100 people per event. For each EA, speakers received speaker fees/
honoraria based on their role (keynote speaker, plenary speaker, breakout speaker, etc.) and 
all lodging and travel costs were paid for by the event sponsors.
All three EAs concluded with planning action and follow-up steps along with related action-
oriented networking. The Planning Committee or a subgroup of the members then formed an 
implementation workgroup with the addition of new leaders and committed volunteers who 
emerged during the meeting. They discussed and reflected on the meeting, and with 
technical assistance from CPCRN staff, moved into action steps.
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4. Three Evidence Academies: collaborations, structure, and responses
Using the Evidence Academy (EA) model (Rohweder et al., 2016), three EAs were held in 
Philadelphia, Pennsylvania between 2015 and 2018. EAs focused on prostate cancer, food 
access/diet and obesity, and tobacco control. These case studies illustrate the various ways 
that each EA was developed, the logistics involved (such as sponsoring partners, time for 
planning, and finances), whether and how we met our participation goals, and concrete 
outcomes. Table 1 provides a high-level overview of the three Evidence Academies. Details 
about each event are described below.
5. Prostate Cancer Evidence Academy, 2015
Prostate cancer is the second most common cancer and a leading cause of cancer death 
among men in the United States (Siegel et al., 2014). Further, African American men are 
about 60% more likely to be diagnosed with prostate cancer and more than twice as likely to 
die from prostate cancer than the general population (Siegel et al., 2014). The causes of 
these disparities are not completely understood but are likely the result of complex 
interactions including genetic, behavioral, environmental, and socioeconomic factors 
(Cooperberg, 2013; Kheirandish and Chinegwundoh, 2011). The community where UPenn 
is located has high proportions of African Americans, increasing the salience of both this 
condition and the impact of racial disparities.
The Prostate Cancer Evidence Academy (PCEA) Planning Committee identified the topics 
to be covered at the EA, including: prostate cancer prevention, early detection, and quality 
treatment; cutting edge technologies, treatment, and research; current best practices in 
prostate cancer prevention and screening; medical treatment decision making; epidemiology 
of prostate cancer; evidence-based interventions (EBIs) to increase screening; using data for 
prostate cancer prevention and control; future directions for public health practice and 
research in prostate cancer; policies, interventions, programs, and resources in the region; 
and prostate cancer activism, education, and survivorship.
A professionally-designed event brochure outlining the objectives, agenda, and featured 
speakers was developed, printed, and distributed through mailing lists to the American 
Urological Association and Oncology Nursing Society, and to physicians on a Marketing 
InFocus List. Local and regional organizations such as the African-Caribbean Cancer 
Consortium, Zero the End of Prostate Cancer, Sidney Kimmel Cancer Center at Jefferson, 
Malecare, Fox Chase Cancer Center, Prostate Cancer International, and the Philadelphia 
Corporation for Aging helped to publicize and promote the event. Electronic brochures were 
distributed widely through local hospital and university listservs, newsletters, and student 
organizations.
The PCEA was a Continuing Medical Education (CME) and Continuing Nursing Education 
(CNE) accredited conference. Those interested in attending were instructed to register for 
the event online through the Penn Medicine Continuing Medical and Interprofessional 
Education (CME-IPCE) Office.
Glanz et al. Page 4
Prev Med. Author manuscript; available in PMC 2020 March 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The PCEA was held in November 2015 with the goals of having participants learn about the 
latest evidence and model programs that make a difference in prostate cancer prevention, 
control, and treatment, and identify follow-up projects to advance prostate cancer control in 
the region. The PCEA was hosted by the UPenn PRC, the CPCRN Collaborating Center, and 
the P60 Center of Excellence in Prostate Cancer Disparities (funded by the National Institute 
on Minority Health and Health Disparities). The CPCRN team led event coordination, with 
substantial assistance from Penn Medicine Abramson Cancer Center. A total of 94 people 
attended the PCEA.
The conference began with morning plenary sessions where speakers provided overviews of 
the latest science on clinical, epidemiological, and public health aspects of prostate cancer. 
The afternoon consisted of breakout sessions for three tracks – clinical, public health/policy, 
and survivorship/advocacy. A lunch keynote address focused on men's health and 
survivorship was followed by a panel discussion on improving prostate cancer outcomes 
through translating research to policy. The last session of the day included working groups 
for each track, which allowed attendees to focus on and discuss the most relevant and 
applicable information and tools for application after the event. All attendees reconvened for 
a group discussion about the working group sessions. Highlights and action items from the 
working groups are outlined in Table 2.
6. Food Access, Diet, and Obesity Evidence Academy, 2017
Obesity is one of the most important health problems of our time. More than one third of 
adults and 17% of children are obese (Hales et al., 2017). The increasing rates of obesity 
contribute to high rates of chronic diseases, such as heart disease and type 2 diabetes. 
Obesity also contributes to the high cost of healthcare. Rates of obesity are often higher in 
low-income and minority populations, and paradoxically, issues of hunger and food 
insecurity co-exist with overnutrition or excess consumption of low-nutrition value foods 
(Hernandez et al., 2017). In Philadelphia, more than 20% of children and 35% of adults are 
obese (City of Philadelphia Department of Public Health, 2018). Obesity is a complex issue 
and a variety of different factors such as home and work environments, the food industry, 
and neighborhood safety can influence obesity in a community – and can provide 
opportunities for healthful, innovative policy and environmental changes.
The EA on “Accelerating Policies and Research on Food Access, Diet, and Obesity 
Prevention” was held in April 2017. This event was hosted by the UPenn PRC and the 
CPCRN Collaborating Center. Additional funding came from the Office of the Vice Provost 
for Research at the University of Pennsylvania.
The goals of this event were to provide a platform to collaborate with leaders in the field to 
prioritize local/regional research and policy efforts to combat obesity, and to focus on the 
dual concerns of overnutrition and food insecurity.
A flyer advertising the event was created. It was distributed widely to the University of 
Pennsylvania, other local universities and public health programs, the Philadelphia 
Department of Public Health, the PRC network, CPCRN, NOPREN, and relevant 
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organizations like The Food Trust. Registration was handled online through a SplashThat 
registration page.
A unique element of this EA was a Public Health Pitch Competition that was held the 
afternoon before the conference. This was an opportunity for students to present their ideas 
about accelerating policies and research on public health and disease prevention. Since a 
goal of EAs is to engage stakeholders, this competition was an innovative way to reach 
early-career scholars and engage them in the EA. Students submitted their ideas and 14 
undergraduate and graduate students were selected to present their ideas to the audience and 
a panel of judges in five minutes. Students presented on a wide range of public health issues, 
as it was determined that requiring the pitches to focus on nutrition or obesity would be too 
limiting. A panel of judges and the audience rated the brief talks using rating forms and 
clickers. Awards of a certificate and $100 were given to the top undergraduate and graduate 
presentations, and a “People's Choice” award was also presented. Winning pitches focused 
on expanding prescription drug take-back programs in pharmacies, resolving malpractice 
dilemmas, and navigating the student health system. Virtually all the audience members and 
student presenters attended the EA the following day.
The main EA event was held the next day with 100 people attending. The conference began 
with a keynote address about supporting healthy eating through nutrition policy and was 
followed by a panel on innovative policy ideas and four breakout sessions. The afternoon 
consisted of a keynote address about community transformation through action around 
hunger and food. The last panel session featured speakers from the PRC network focusing 
on translating research into high-impact policy. This event helped to strengthen current 
connections and build new collaborations between obesity researchers, policy makers, and 
community partners.
7. Tobacco Control Evidence Academy, 2018
Tobacco use is a leading cause of preventable disease and death in the United States, and is a 
concern for both adults and youth (Odani et al., 2018; Wang et al., 2018). The rise in e-
cigarette use, or vaping, presents new challenges to battling a public health threat that had 
been declining in past decades (Prochaska, 2019). The fast-moving field of tobacco control 
science was identified as the top priority for the next Evidence Academy in a voting process 
by cancer control researchers at UPenn.
The goal of the Tobacco Control Science Evidence Academy (TCSEA) was to engage public 
health professionals, policy makers, researchers, and clinicians, to inform them of the most 
up-to-date research on tobacco, and to bridge the gap between research, policy, and practice. 
The TCSEA was hosted by the UPenn PRC, the CPCRN Collaborating Center, and the 
UPenn Abramson Cancer Center.
Publicity included digital flyers and registration information distributed via email and social 
media across the University, and to organizations in the greater Philadelphia area. The 
TCSEA was held in November 2018 and 77 people attended.
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The conference began with three morning plenary sessions providing an overview of the 
latest about new tobacco product marketing, clinical and biobehavioral research, and tobacco 
cessation programs. Concurrent breakout sessions were held in three tracks: clinical, 
research, and policy/action. The lunch keynote address was about e-cigarettes, followed by a 
panel about tobacco control in Philadelphia. Afterwards, a flash talk session featured six-
minute presentations by five speakers about their research, programs, or policy initiatives. 
Similar to the pitch competition at the previous EA, this session was meant to engage 
graduate students and early career scholars and give them an opportunity to both present 
their work and network with other researchers. Participants then attended three workgroups 
in the same tracks as the morning breakout sessions to discuss themes from the day. The day 
concluded with a large group session to share information from the workgroups and talk 
about next steps.
Across the three workgroup tracks (clinical, research, and policy/action), several common 
themes emerged during discussion sessions among attendees. First, there is significant 
interest in e-cigarettes, particularly because of their potential to be both helpful and 
dangerous. Second, technology, specifically smartphones, should be further integrated into 
research. Third, special efforts should be made to reach and study populations such as 
pregnant women, youth, and tobacco users who do not seek out cessation treatment. Fourth, 
links between tobacco and marijuana use should be better understood.
8. Evaluation and follow-up activities
Across all events, evaluations showed that at least 80% of attendees rated each session as 
“very good” or “excellent.” Attendees reported that they liked the multidisciplinary 
approach, the action-oriented presentations, the wide range of people in attendance, the 
variety and quality of the speakers, and the ability to network with others.
PCEA evaluations indicated that participants would be able to implement new ideas and 
practices learned at the EA. Additionally, attendees working in clinical settings shared that 
the content could be used to improve care. Food access EA attendees reported that they 
planned to use the information learned in educational settings and school-based programs, 
for program evaluation, to build new partnerships, and for advocacy and volunteer work. 
TCSEA participants reported learning cutting-edge information about emerging areas of 
public health concern and planned to integrate what they learned in their own work, 
including social media campaigns and future research. These responses suggest that the 
short-term outcomes of knowledge transfer, increased awareness, and the establishment of 
new partnerships were achieved. (A version of the evaluation form used is available upon 
request from the authors.)
Follow-up actions from the PCEA included convening interested participants and obtaining 
funding for a pilot study of active surveillance of men diagnosed with early-stage prostate 
cancer. In addition, new research collaborations emerged from the PCEA that led to two 
other studies of prostate cancer disparities and community-engaged action (McIntire et al., 
2018). There were no specific follow-up projects initiated as a result of the food access EA, 
but initiatives in nutrition, food access, and food policy are ongoing at UPenn and with 
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community partners. Follow-up from the TCSEA included new partnerships and 
collaborative projects between UPenn and the City of Philadelphia.
9. Discussion
The development and conduct of each of the three Evidence Academies led to significant 
cumulative learning for our CPCRN Collaborating Center team (Michener et al., 2012). 
Here we highlight some “lessons learned” across the three EAs that other groups planning 
EAs can consider in their future endeavors. These points were determined by the planning 
team based on evaluations, notes taken during the EAs, and from in-person discussions 
among the team, with the planning committee, and with attendees.
9.1. Collaborating partners and planning committees are important and helpful
The EAs hosted at the University of Pennsylvania used the model originally developed by 
the CPCRN site at the University of North Carolina (UNC) (Rohweder et al., 2016). Our co-
author, Cathy Melvin, developed the EA concept and led the UNC CPCRN when the EAs 
were first initiated and provided input, guidance, and advice during the planning processes 
for these EAs. She also attended the Prostate Cancer Evidence Academy in 2015 and led the 
afternoon group discussion. Her help was invaluable in applying the EA model to our local 
context.
Planning Committees for each EA included university faculty members, staff and students, 
and local public health leaders. For the 2017 “Food Access, Diet, and Obesity” EA, we 
invited colleagues from the national PRC network to serve on the planning committee, as 
judges, and as panel speakers at the meeting. While it can be challenging to convene 
Planning Committee meetings, it was our experience that the committee members shaped 
the EAs into more engaging and vibrant events than they would have been without their 
input. The planners were also key to attracting broad audiences to the events.
The original EA model emphasizes the importance of a local focus for the conference 
content, which the Planning Committee helps ensure. This aspect of the EA model is a 
significant strength, but can also be a limitation in that it makes planning difficult to scale or 
easily transfer to other sites. For example, partnerships and institutional ties are essential for 
almost every step of the planning and execution of the EA, including securing funding, 
assembling the planning committee, recruiting speakers, and publicizing the event. We found 
these relationships vital to successful events, but it is up to the team on the ground to 
leverage their specific partnerships.
9.2. Costs, CE credits and planning time
The cost of the Evidence Academies ranged from $26,772 to $45,551, which included 
speaker fees, speaker travel and accommodations, event space, AV expenses, catering, 
publicity and audience generation costs, and printing costs (programs, meetings materials, 
signage). Also, a Planning Committee/Speaker dinner was held at a local restaurant the night 
before each Evidence Academy. This further facilitated collaborations and connections in a 
more informal atmosphere. These direct costs do not include faculty and staff time, which 
were supported through the CPCRN, UPenn PRC, and other grants related to the foci of the 
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EAs. The registration fee revenue covered only a small part of the direct costs, so we 
identified funding from non-PRC grants and from co-sponsors on campus and in the region. 
No pharmaceutical or industry contributions were used for the EAs.
We offered CME/CNE credits for the Prostate Cancer Evidence Academy in 2015, to 
encourage attendance and participation from clinicians. Of the 94 people in attendance 
during this event, 24 attendees received CME/CNE credit. However, the costs and staff effort 
required to be a CME/CNE-certified course were high and the cost-to-benefit ratio was poor. 
Therefore, in consultation with the Planning Committees we decided not to offer CME/CNE 
credits for the next two EAs. Also, we purchased commercial mailing lists of clinicians for 
the PCEA and sent a professionally designed brochure to over 7000 people. For the other 
EAs, we found that targeted publicity and e-invites were equally effective and much less 
costly.
While we expected that planning for each EA would take four to six months, at least nine 
months lead time was a more realistic estimate. The tasks requiring the most advance notice 
were booking high-quality, flexible, and affordable conference spaces and scheduling 
plenary speakers.
9.3. Follow-up activities and collaborations
All three EAs attracted sizable audiences that exceeded our minimum goals of 50 
participants. Further, each Evidence Academy led to new activities and collaborations. The 
most vigorous follow-up was after the PCEA (Table 2), when a Follow-up Planning Survey 
was conducted. Based on the results, we convened a Survivorship and Advocacy Workgroup 
to discuss action plans from the event and to brainstorm next steps. This work group decided 
to prioritize two areas – active surveillance and awareness about prostate cancer, specifically 
among African American men and women. Because of these conversations, we applied for 
and received internal pilot grant funds to study patient and provider perspectives around 
active surveillance. That project is now complete and manuscripts are under review. Follow-
up Planning Surveys were not used with the other two EAs because existing structures and 
ongoing initiatives were already in place for these content areas.
10. Conclusion
The overarching goals of the Evidence Academies are to enhance knowledge transfer, 
awareness, and partnerships, and to promote adoption of EBIs and priorities for improved 
cancer prevention and control (Rohweder et al., 2016; Stamatakis et al., 2013). The long-
term impact should be reduced morbidity, mortality, and health disparities in regions where 
EAs are held.
The three Evidence Academies described here were very highly rated and met their goals of 
bringing together different stakeholders to enhance knowledge transfer, awareness, and 
partnerships. The Evidence Academy events also contributed to collaborations on new and 
ongoing research projects, increased communication between University faculty/staff and 
state and local health department leadership/staff, and fostered connections among 
researchers, community organizations, and existing resources.
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While positive outcomes were attained in this use of the EA model, the EA model overall, 
its components, and various adaptations of it have not been evaluated as to overall 
effectiveness in achieving stated goals compared to other types of educational, 
communication, dissemination, or implementation strategies. For example, comparing long-
term outcomes (like the speed of translation of evidence into practice) from EAs to those 
from more traditional conferences that do not have the same discussion and networking 
emphasis would help identify the relative advantage of this aspect of EAs. Future research 
opportunities exist to use information such as that presented in this paper to advance our 
understanding of whether the EA model is a robust intervention strategy to move evidence 
into practice.
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Fig. 1. Prostate Cancer Evidence Academy logic model.
*These are unique features of the Evidence Academy model.
(Adapted from: Rohweder, C., Laping, J., Diehl, S., Moore, A., Isler, M., Scott, J., … 
Melvin, C. (2016). Bridging Research, Practice, and Policy: The “Evidence Academy” 
Conference Model. Journal of Public Health Management and Practice, 1–4.)
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